Lakefront BiotherapeuticsEURONEXT: LKFT

Galapagos Receives Transparency Notifications from Bank of America

· Issued by Lakefront Biotherapeutics

Mechelen, Belgium; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.

Pursuant to Belgian transparency legislation1, Galapagos received transparency notifications from Bank of America Corporation on March 5 and 6, 2026. The initial notification indicates that Bank of America Corporation, as controlling entity, fell below the 5% threshold for equivalent financial instruments relating to Galapagos’ voting rights on March 3, 2026, as a result of the disposal of such instruments. A subsequent notification received on March 6, 2026 indicates that Bank of America Corporation, as controlling entity, crossed above the 5% threshold for equivalent financial instruments relating to Galapagos’ voting rights again on March 4, 2026, following the acquisition of such instruments.

On March 6, 2026, Bank of America Corporation (taking into account the holding of its affiliates) owned 335,202 voting rights and 3,489,591 equivalent financial instruments, representing together 5.80% of Galapagos’ currently outstanding 65,897,071 shares.

Summary of the transactions:

Date on which the threshold was crossed

Date of notification

Direct voting rights after the transaction

Equivalent financial instruments after the transaction

Total (%)
voting rights

March 5, 2026

March 3, 2026

1.00%

4.70%

5.70%

March 6, 2026

March 4, 2026

0.51%

5.30%

5.80%

Content of the notifications from Bank of America Corporation:
The notification dated March 6, 2026, contains the following information:

  • Date of notification: March 6, 2026

  • Date on which the threshold is crossed: March 4, 2026

  • Threshold of voting rights crossed (in %): 5%

  • Notification by: Bank of America Corporation

  • Denominator: 65,897,071

  • Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities

  • Notified details:

A) Voting Rights

Previous notification

After the transaction

# of voting rights

# of voting rights

% of voting rights

Holder of voting rights

Linked to securities

Not linked to securities

Linked to securities

Not linked to securities

Bank of America Corporation

0

0

0.00%

Bank of America, National Association

12,440

12,440

0.02%

Merrill Lynch International

101,655

128,053

0.19%

Managed Account Advisors LLC

3

3

0.00%

BofA Securities, Inc.

530,639

180,123

0.27%

Merrill Lynch, Pierce, Fenner & Smith
Incorporated

14,462

14,462

0.02%

U.S. Trust Company of Delaware

121

121

0.00%

Subtotal

659,330

335,202

0.51%

TOTAL

335,202

0

0.51%

0.00%

B) Equivalent financial instruments

After the transaction

Holder of equivalent financial instruments

Type of financial instrument

Expiration date

Exercise period or date

# of voting rights that may be acquired if the instrument is exercised

% of voting rights

Settlement

Merrill Lynch International

Right to Recall

132,666

0.20%

physical

BofA Securities, Inc.

Right to Recall

23,200

0.04%

physical

BofA Securities, Inc.

Rights of Use

3,174,135

4.82%

physical

Merrill Lynch International

Physical Call Option

19/06/2026

100,000

0.15%

physical

Bank of America, National Association

Swaps

31/01/2028

263

0.00%

cash

Bank of America, National Association

Swaps

15/04/2027

14,679

0.02%

cash

Bank of America, National Association

Swaps

29/02/2028

846

0.00%

cash

Merrill Lynch International

Swaps

15/01/2027

8,056

0.01%

cash

Merrill Lynch International

Swaps

30/04/2026

12,050

0.02%

cash

Merrill Lynch International

Swaps

02/07/2026

964

0.00%

cash

Merrill Lynch International

Swaps

01/11/2027

5,726

0.01%

cash

Merrill Lynch International

Swaps

15/04/2027

14,679

0.02%

cash

Merrill Lynch International

Swaps

30/06/2026

101

0.00%

cash

Merrill Lynch International

Swaps

31/03/2027

285

0.00%

cash

Merrill Lynch International

Swaps

09/09/2027

945

0.00%

cash

Merrill Lynch International

Swaps

29/12/2027

996

0.00%

cash

TOTAL

3,489,591

5.30%

TOTAL (A&B)

# of voting rights

% of voting rights

3,824,793

5.80%

The chain of control has been described at the end of the notification (section 11) and can be found here.

Content of the notifications from Bank of America Corporation:
The notification dated March 5, 2026, contains the following information:

  • Date of notification: March 5, 2026

  • Date on which the threshold is crossed: March 3, 2026

  • Threshold of voting rights crossed (in %): 5%

  • Notification by: Bank of America Corporation

  • Denominator: 65,897,071

  • Reason for the notification: Acquisition or disposal of financial instruments that are treated as voting securities

  • Notified details:

A) Voting Rights

Previous notification

After the transaction

# of voting rights

# of voting rights

% of voting rights

Holder of voting rights

Linked to securities

Not linked to securities

Linked to securities

Not linked to securities

Bank of America Corporation

0

0

0.00%

Bank of America, National Association

12,440

12,440

0.02%

Merrill Lynch International

95,048

101,665

0.15%

Managed Account Advisors LLC

3

3

0.00%

BofA Securities, Inc.

170,568

530,639

0.81%

Merrill Lynch, Pierce, Fenner & Smith
Incorporated

14,462

14,462

0.02%

U.S. Trust Company of Delaware

121

121

0.00%

Subtotal

292,642

659,330

1.00%

TOTAL

659,330

0

1.00%

0.00%

B) Equivalent financial instruments

After the transaction

Holder of equivalent financial instruments

Type of financial instrument

Expiration date

Exercise period or date

# of voting rights that may be acquired if the instrument is exercised

% of voting rights

Settlement

Merrill Lynch International

Right to Recall

141,684

0.22%

physical

BofA Securities, Inc.

Right to Recall

23,200

0.04%

physical

BofA Securities, Inc.

Rights of Use

2,776,259

4.21%

physical

Merrill Lynch International

Physical Call Option

19/06/2026

100,000

0.15%

physical

Bank of America, National Association

Swaps

31/01/2028

663

0.00%

cash

Bank of America, National Association

Swaps

15/04/2027

14,679

0.02%

cash

Bank of America, National Association

Swaps

29/02/2028

741

0.00%

cash

Merrill Lynch International

Swaps

15/01/2027

8,056

0.01%

cash

Merrill Lynch International

Swaps

30/04/2026

12,750

0.02%

cash

Merrill Lynch International

Swaps

02/07/2026

1,028

0.00%

cash

Merrill Lynch International

Swaps

01/11/2027

5,726

0.01%

cash

Merrill Lynch International

Swaps

15/04/2027

14,679

0.02%

cash

Merrill Lynch International

Swaps

30/06/2026

34

0.00%

cash

Merrill Lynch International

Swaps

29/01/2027

187

0.00%

cash

TOTAL

3,099,686

4.70%

TOTAL (A&B)

# of voting rights

% of voting rights

3,759,016

5.70%

The chain of control has been described at the end of the notification (section 11) and can be found here.

About Galapagos
Galapagos is a biotechnology company built to bring meaningful medicines to patients with serious diseases in therapeutic areas of unmet need. The Company combines world-class deal making expertise with capital to identify, acquire, and advance promising opportunities that have the potential to drive value for patients and shareholders. Applying a modality-agnostic asset selection approach and operational flexibility, Galapagos prioritizes oncology and immunology & inflammation programs with clear clinical proof-of-concept in emerging areas. For more information, visit www.glpg.com or follow us on LinkedIn or X.

For further information, contact Galapagos:
Investor Relations
Glenn Schulman

+1 412 522 6239
ir@glpg.com

Media
Media
Katie Morris
+1 952 288 6821
katiemorris@ententeinc.com

1 Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market and regarding miscellaneous provisions, as amended from time to time.

Attachment